ASCO 2019 | CAR-T for ALL: bridging options and choices

Name: CAR-T for ALL: bridging options and choices
Uploaded: 2019-06-01T00:00:00.000Z
Duration: 1 min
Description: Karlo Perica, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York, NY, explains the options clinicians have when choosing bridging options for acute lymphoblastic leukemia (ALL) patients undergoing CAR T-cell therapy, and how decisions are made. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Karlo Perica • 1 Jun 2019

ASCO 2019

Acute Lymphoblastic Leukemia

Karlo Perica, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York, NY, explains the options clinicians have when choosing bridging options for acute lymphoblastic leukemia (ALL) patients undergoing CAR T-cell therapy, and how decisions are made. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.